Yet even though Mr. Crowley had moved mountains on the scientific and business fronts to get the treatment into testing, he couldn’t seem to speed the drug to his own rapidly weakening children. When he sold his company, he gave up control of the medicine they needed. The shortage of the drug, conflict-of-interest questions and Genzyme’s own internal protocols rose up in his path. His personal goal — getting the drug to his kids — at times conflicted with the company’s view of how to get the drug to market as soon as possible. —Geeta Anand —For His Sick Kids, a Father Struggled to Develop a Cure (Wall Street Journal)